WoodTrust Financial Corp Boosts Holdings in Neogen Co. (NASDAQ:NEOG)

WoodTrust Financial Corp boosted its position in shares of Neogen Co. (NASDAQ:NEOG) by 19.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 55,925 shares of the company’s stock after purchasing an additional 9,000 shares during the quarter. WoodTrust Financial Corp’s holdings in Neogen were worth $940,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of NEOG. Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of Neogen by 67.5% during the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 616,190 shares of the company’s stock valued at $9,723,000 after buying an additional 248,340 shares during the last quarter. SG Americas Securities LLC boosted its stake in Neogen by 277.1% during the 1st quarter. SG Americas Securities LLC now owns 45,558 shares of the company’s stock valued at $719,000 after purchasing an additional 33,478 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in shares of Neogen by 73.4% in the 1st quarter. BNP Paribas Financial Markets now owns 115,830 shares of the company’s stock worth $1,828,000 after purchasing an additional 49,041 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new position in shares of Neogen in the second quarter worth $5,714,000. Finally, Oppenheimer Asset Management Inc. lifted its holdings in shares of Neogen by 39.8% during the second quarter. Oppenheimer Asset Management Inc. now owns 103,611 shares of the company’s stock valued at $1,619,000 after purchasing an additional 29,489 shares in the last quarter. 96.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Piper Sandler lifted their price objective on Neogen from $17.00 to $17.50 and gave the stock a “neutral” rating in a report on Tuesday, August 6th. StockNews.com upgraded shares of Neogen to a “sell” rating in a research note on Monday, September 30th.

Insider Activity

In other Neogen news, CEO John Edward Adent acquired 14,500 shares of the company’s stock in a transaction that occurred on Friday, October 11th. The shares were bought at an average price of $13.80 per share, with a total value of $200,100.00. Following the completion of the acquisition, the chief executive officer now owns 216,477 shares in the company, valued at $2,987,382.60. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.13% of the company’s stock.

Neogen Price Performance

Shares of NEOG opened at $15.62 on Thursday. The firm has a fifty day simple moving average of $15.43 and a two-hundred day simple moving average of $15.29. The firm has a market cap of $3.38 billion, a PE ratio of -142.00 and a beta of 1.23. The company has a current ratio of 4.41, a quick ratio of 2.79 and a debt-to-equity ratio of 0.28. Neogen Co. has a 1-year low of $11.46 and a 1-year high of $20.89.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings data on Thursday, October 10th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). The firm had revenue of $217.00 million for the quarter, compared to analysts’ expectations of $215.05 million. Neogen had a negative net margin of 2.58% and a positive return on equity of 2.80%. The firm’s revenue was down 5.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.11 EPS. On average, equities analysts anticipate that Neogen Co. will post 0.52 EPS for the current year.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.